Treosulfan-based Conditioning for Transplantation in AML/MDS

Update Il y a 4 ans
Reference: NCT00491634

Woman and Man

  • | Country :
  • Israel
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The study hypotheses is that the introduction of dose escalated treosulfan, in substitution to busulfan, will reduce toxicity after allogeneic transplantation while improving myeloablation and and disease control in patients with AML and MDS not eligible for standard transplantation.


Inclusion criteria

  • Acute Myeloid Leukemia ,myelodysplastic syndrome

Links